$321 Million is the total value of DAFNA Capital Management LLC's 75 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 24.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR S&P BIOTECH ETFetf | $41,256,300 | -12.2% | 565,000 | 0.0% | 12.83% | -0.2% | |
| STXS | STEREOTAXIS INC | $21,615,275 | +3.3% | 13,680,554 | 0.0% | 6.72% | +17.5% | |
| CYTK | Buy | CYTOKINETICS INC | $14,127,189 | +30.2% | 479,538 | +44.1% | 4.39% | +48.0% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $13,485,144 | +19.6% | 499,820 | +4.2% | 4.20% | +36.1% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $13,103,546 | -4.4% | 473,394 | -7.6% | 4.08% | +8.8% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $12,754,892 | +5.7% | 136,212 | +0.7% | 3.97% | +20.2% |
| IBB | ISHARES NASDAQ BIOTECH INDXetf | $12,534,725 | -3.7% | 102,500 | 0.0% | 3.90% | +9.6% | |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $12,530,945 | -21.2% | 249,521 | -0.8% | 3.90% | -10.3% |
| MRUS | Buy | MERUS N V | $11,433,235 | +12.8% | 484,870 | +26.0% | 3.56% | +28.3% |
| XENE | XENON PHARMACEUTICALS INC | $9,583,178 | -11.3% | 280,538 | 0.0% | 2.98% | +0.9% | |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $8,940,296 | -2.2% | 52,873 | +25.4% | 2.78% | +11.2% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $8,281,688 | +17.7% | 73,615 | -1.3% | 2.58% | +33.9% |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $7,195,901 | +18.8% | 586,463 | +15.7% | 2.24% | +35.1% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $6,655,576 | -29.5% | 458,373 | +1.7% | 2.07% | -19.8% |
| DXCM | DEXCOM INC | $6,302,602 | -27.4% | 67,552 | 0.0% | 1.96% | -17.4% | |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $5,831,273 | +6.0% | 605,532 | -0.9% | 1.81% | +20.6% |
| Buy | 2SEVENTY BIO INC | $5,674,063 | +12.9% | 1,447,465 | +191.6% | 1.76% | +28.5% | |
| ATRC | ATRICURE INC | $5,498,170 | -11.3% | 125,529 | 0.0% | 1.71% | +0.9% | |
| MORF | Buy | MORPHIC HOLDING INC | $5,309,347 | -55.2% | 231,748 | +12.1% | 1.65% | -49.1% |
| KURA | Buy | KURA ONCOLOGY INC | $5,023,150 | +32.7% | 550,784 | +53.9% | 1.56% | +50.9% |
| AXGN | Buy | AXOGEN INC | $4,679,470 | +54.3% | 935,894 | +181.8% | 1.46% | +75.6% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $4,616,160 | +15.2% | 652,000 | +14.6% | 1.44% | +31.1% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $4,584,105 | +69.8% | 220,708 | +100.6% | 1.43% | +93.2% |
| NRIX | NURIX THERAPEUTICS INC | $4,375,623 | -21.3% | 556,695 | 0.0% | 1.36% | -10.5% | |
| ALEC | Sell | ALECTOR INC | $4,075,518 | +6.1% | 628,938 | -1.6% | 1.27% | +20.8% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $4,046,158 | +18.3% | 92,887 | -1.9% | 1.26% | +34.5% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $3,997,770 | -12.8% | 222,717 | -1.3% | 1.24% | -0.7% |
| ASCENDIS PHARMA A/Snote 2.250% 4/0 | $3,691,250 | +1.8% | 4,000,000 | 0.0% | 1.15% | +15.7% | ||
| VKTX | Buy | VIKING THERAPEUTICS INC | $3,538,581 | -25.7% | 319,655 | +8.9% | 1.10% | -15.4% |
| ARAY | ACCURAY INC | $3,324,814 | -29.7% | 1,222,358 | 0.0% | 1.03% | -20.0% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $2,976,070 | -26.1% | 519,384 | 0.0% | 0.93% | -15.9% | |
| MEDIWOUND LTD | $2,741,428 | -0.2% | 257,653 | 0.0% | 0.85% | +13.6% | ||
| IPSC | CENTURY THERAPEUTICS INC | $2,614,814 | -36.7% | 1,307,407 | 0.0% | 0.81% | -28.1% | |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $2,454,998 | -21.3% | 122,200 | 0.0% | 0.76% | -10.4% | |
| New | AMYLYX PHARMACEUTICALS INC | $2,243,836 | – | 122,547 | +100.0% | 0.70% | – | |
| Buy | PROCEPT BIOROBOTICS CORP | $2,208,113 | +680.8% | 67,300 | +741.2% | 0.69% | +792.2% | |
| Buy | ASTRIA THERAPEUTICS INC | $2,204,378 | +107.3% | 295,493 | +131.5% | 0.69% | +135.7% | |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $2,162,829 | -2.3% | 928,253 | -0.2% | 0.67% | +11.2% |
| KROS | Buy | KEROS THERAPEUTICS INC | $2,102,837 | +9.8% | 65,961 | +38.4% | 0.65% | +24.8% |
| GLPG | Buy | GALAPAGOS NVspon adr | $2,079,046 | -2.9% | 60,175 | +14.2% | 0.65% | +10.4% |
| New | THIRD HARMONIC BIO INC | $1,917,000 | – | 300,000 | +100.0% | 0.60% | – | |
| BWAY | Sell | BRAINSWAY LTDsponsored ads | $1,746,011 | +51.7% | 432,181 | -14.4% | 0.54% | +72.4% |
| REGULUS THERAPEUTICS INC | $1,522,137 | -6.8% | 1,111,049 | 0.0% | 0.47% | +5.8% | ||
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $1,428,200 | – | 193,000 | +100.0% | 0.44% | – |
| CERE | New | CEREVEL THERAPEUTICS HOLDINGS INC | $1,357,826 | – | 62,200 | +100.0% | 0.42% | – |
| IMGN | New | IMMUNOGEN INC | $1,317,210 | – | 83,000 | +100.0% | 0.41% | – |
| LRMR | Sell | LARIMAR THERAPEUTICS INC | $1,293,123 | +17.9% | 327,373 | -6.6% | 0.40% | +34.0% |
| SPRB | Buy | SPRUCE BIOSCIENCES INC | $1,288,494 | +92.1% | 570,130 | +82.7% | 0.40% | +119.1% |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCspon ads | $1,241,642 | -6.8% | 962,513 | -4.6% | 0.39% | +6.0% |
| GOSS | New | GOSSAMER BIO INC | $1,229,256 | – | 1,476,052 | +100.0% | 0.38% | – |
| PRQR | PROQR THERAPEUTICS N V | $1,222,757 | -19.8% | 940,582 | 0.0% | 0.38% | -8.9% | |
| MGNX | New | MACROGENICS INC | $1,204,591 | – | 258,496 | +100.0% | 0.38% | – |
| CGEM | New | CULLINAN ONCOLOGY INC | $1,151,920 | – | 127,284 | +100.0% | 0.36% | – |
| ACET | ADICET BIO INC | $1,091,964 | -43.6% | 797,054 | 0.0% | 0.34% | -35.8% | |
| ITOS | ITEOS THERAPEUTICS INC | $1,079,232 | -17.3% | 98,560 | 0.0% | 0.34% | -5.9% | |
| SYROS PHARMACEUTICALS INC | $1,050,218 | +25.4% | 265,878 | 0.0% | 0.33% | +42.8% | ||
| STRO | Buy | SUTRO BIOPHARMA INC | $982,284 | -13.0% | 283,079 | +16.6% | 0.31% | -1.0% |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $932,228 | -65.1% | 734,038 | -9.5% | 0.29% | -60.2% |
| VIGIL NEUROSCIENCE INC | $928,740 | -42.7% | 172,308 | 0.0% | 0.29% | -34.8% | ||
| Buy | BIOHAVEN LTD | $910,350 | +80.3% | 35,000 | +65.8% | 0.28% | +105.1% | |
| IMVT | New | IMMUNOVANT INC | $863,775 | – | 22,500 | +100.0% | 0.27% | – |
| ACRIVON THERAPEUTICS INC | $734,705 | -26.2% | 76,852 | 0.0% | 0.23% | -15.8% | ||
| NVRO | NEVRO CORP | $538,160 | -24.4% | 28,000 | 0.0% | 0.17% | -14.4% | |
| STIM | NEURONETICS INC | $423,518 | -37.2% | 313,717 | 0.0% | 0.13% | -28.3% | |
| ELEV | ELEVATION ONCOLOGY INC | $298,170 | -56.4% | 450,000 | 0.0% | 0.09% | -50.3% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $273,830 | -15.7% | 351,064 | 0.0% | 0.08% | -4.5% | |
| MASI | MASIMO CORP | $263,040 | -46.7% | 3,000 | 0.0% | 0.08% | -39.3% | |
| KPTI | KARYOPHARM THERAPEUTICS INC | $258,189 | -25.1% | 192,678 | 0.0% | 0.08% | -14.9% | |
| CMPX | COMPASS THERAPEUTICS INC | $230,258 | -38.1% | 116,882 | 0.0% | 0.07% | -29.4% | |
| NXTC | Sell | NEXTCURE INC | $214,379 | -36.5% | 166,185 | -11.5% | 0.07% | -27.2% |
| CGEN | COMPUGEN LTDord | $190,838 | -18.4% | 205,202 | 0.0% | 0.06% | -7.8% | |
| SPRO | SPERO THERAPEUTICS INC | $151,250 | -16.6% | 125,000 | 0.0% | 0.05% | -6.0% | |
| KNTE | Buy | KINNATE BIOPHARMA INC | $147,251 | -39.4% | 105,179 | +31.2% | 0.05% | -30.3% |
| INGN | INOGEN INC | $78,300 | -54.8% | 15,000 | 0.0% | 0.02% | -48.9% | |
| New | ACELYRIN INC | $74,241 | – | 7,300 | +100.0% | 0.02% | – | |
| LCTX | Exit | LINEAGE CELL THERAPEUTICS IN | $0 | – | -140,000 | -100.0% | -0.05% | – |
| MDNA | Exit | MEDICENNA THERAPEUTICS CORP | $0 | – | -660,000 | -100.0% | -0.09% | – |
| Exit | PARDES BIOSCIENCES INC | $0 | – | -430,291 | -100.0% | -0.21% | – | |
| SURF | Exit | SURFACE ONCOLOGY INC | $0 | – | -1,100,000 | -100.0% | -0.26% | – |
| LYRA | Exit | LYRA THERAPEUTICS INC | $0 | – | -361,084 | -100.0% | -0.41% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -127,585 | -100.0% | -1.62% | – | |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -180,306 | -100.0% | -2.32% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -612,975 | -100.0% | -6.59% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.